Piper Jaffray Firms Weighs in on Tenet Healthcare Corp’s Q2 2019 Earnings (NYSE:THC)

[ad_1]

Tenet Healthcare Corp (NYSE:THC) – Investigation analysts at Piper Jaffray Firms lowered their Q2 2019 EPS estimates for shares of Tenet Healthcare in a study note issued to investors on Tuesday, April 30th, Zacks Investment Investigation reports. Piper Jaffray Firms analyst S. James now anticipates that the organization will earn $.42 per share for the quarter, down from their preceding estimate of $.63. Piper Jaffray Firms also issued estimates for Tenet Healthcare’s Q3 2019 earnings at $.52 EPS, FY2019 earnings at $two.43 EPS, Q1 2020 earnings at $.27 EPS, Q2 2020 earnings at $.47 EPS, Q3 2020 earnings at $.42 EPS and FY2020 earnings at $1.91 EPS.

Tenet Healthcare (NYSE:THC) final announced its earnings outcomes on Monday, April 29th. The organization reported $.54 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $.29 by $.25. The organization had income of $four.55 billion in the course of the quarter, compared to the consensus estimate of $four.51 billion. Tenet Healthcare had a damaging net margin of .04% and a constructive return on equity of 29.29%. The firm’s income for the quarter was down three.three% on a year-more than-year basis. For the duration of the very same quarter in the prior year, the organization posted $.57 earnings per share.

Other analysts also lately issued study reports about the stock. Raymond James improved their target price tag on shares of Tenet Healthcare from $37.00 to $47.00 in a report on Wednesday, February 27th. Citigroup improved their target price tag on shares of Tenet Healthcare from $35.00 to $37.00 and gave the organization a “buy” rating in a report on Wednesday, February 27th. Mizuho restated a “buy” rating and set a $28.00 price tag objective on shares of Tenet Healthcare in a report on Monday, January 28th. TheStreet downgraded shares of Tenet Healthcare from a “c” rating to a “d+” rating in a report on Monday, Could 13th. Ultimately, Barclays set a $24.00 price tag objective on shares of Tenet Healthcare and gave the stock a “hold” rating in a report on Wednesday, April 17th. Two study analysts have rated the stock with a sell rating, ten have issued a hold rating and 3 have issued a get rating to the organization. Tenet Healthcare presently has an typical rating of “Hold” and a consensus price tag target of $30.07.

Shares of THC stock opened at $20.84 on Friday. The stock has a industry capitalization of $two.15 billion, a PE ratio of 11.20, a PEG ratio of .38 and a beta of 1.68. The organization has a debt-to-equity ratio of 21.98, a present ratio of 1.23 and a fast ratio of 1.15. Tenet Healthcare has a a single year low of $16.60 and a a single year higher of $39.74.

Institutional investors and hedge funds have lately purchased and sold shares of the organization. Oregon Public Staff Retirement Fund improved its stake in shares of Tenet Healthcare by 1,653.four% in the fourth quarter. Oregon Public Staff Retirement Fund now owns 565,569 shares of the company’s stock worth $33,00 just after buying an further 533,313 shares in the final quarter. Enlightenment Investigation LLC bought a new position in shares of Tenet Healthcare in the fourth quarter worth about $36,00. PNC Economic Solutions Group Inc. improved its stake in shares of Tenet Healthcare by 101.9% in the 1st quarter. PNC Economic Solutions Group Inc. now owns 1,351 shares of the company’s stock worth $38,00 just after buying an further 682 shares in the final quarter. Pearl River Capital LLC bought a new position in shares of Tenet Healthcare in the fourth quarter worth about $41,00. Ultimately, Economic Gravity Wealth Inc. bought a new position in shares of Tenet Healthcare in the 1st quarter worth about $51,00.

About Tenet Healthcare

Tenet Healthcare Corporation operates as a diversified healthcare solutions organization. The organization operates in 3 segments: Hospital Operations and Other, Ambulatory Care, and Conifer. Its basic hospitals present acute care solutions, operating and recovery rooms, radiology and respiratory therapy solutions, clinical laboratories, and pharmacies.

Featured Story: Technical Evaluation

Get a no cost copy of the Zacks study report on Tenet Healthcare (THC)

For far more details about study offerings from Zacks Investment Investigation, check out Zacks.com

Earnings History and Estimates for Tenet Healthcare (NYSE:THC)

Acquire News &amp Ratings for Tenet Healthcare Each day – Enter your e-mail address under to acquire a concise every day summary of the most recent news and analysts’ ratings for Tenet Healthcare and associated firms with MarketBeat.com’s Absolutely free every day e-mail newsletter.

[ad_2]

Latest posts